Expression of Growth Factors and Secretory Leukocyte Protease Inhibitor (SLPI) in RAW264.7 Cells after Lipopolysaccharide (LPS) Stimulation |
Son, Wook-Hee
(Department of Conservative Dentistry, College of Dentistry, Chosun University)
Choi, Baik-Dong (Department of Oral Histology, College of Dentistry, Chosun University) Jeong, Soon-Jeong (Department of Oral Histology, College of Dentistry, Chosun University) Wang, Guan-Lin (Department of Oral Histology, College of Dentistry, Chosun University) Hwang, Ho-Keel (Department of Conservative Dentistry, College of Dentistry, Chosun University) Jeong, Moon-Jin (Department of Conservative Dentistry, College of Dentistry, Chosun University) |
1 | Abe T, Kobayashi N, Yoshimura K, Trapnell BC, Kim H, Hubbard RC, Brewer MT, Thompson RC, Crystal RG: Expression of the secretory leukoprotease inhibitor gene in epithelial cells. J Clin Invest 87 : 2207-2215, 1991 DOI |
2 | Cai Q, Lanting L, Natarajan R: Growth factors induce monocyte binding to vascular smooth muscle cells: implications for monocyte retention in atherosclerosis. Am J Physiol Cell Physiol 287 : 707-714, 2004 DOI ScienceOn |
3 | Marino MW, Dunn A, Grail D, Inglese M, Noguchi Y, Richards E, Jungbluth A, Wada H, Moore M, Williamson B, Basu S, Old LJ: Characterization of tumor necrosis factor-deficient mice. Proc Natl Acad Sci USA 94 : 8093-8098, 1997 |
4 | Peoples GE, Blotnick S, Takahashi K, Freeman MR, Klagsbrun M, Eberlein TJ: T lymphocytes that infiltrate tumors and atherosclerotic plaques produce heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor: a potential pathologic role. Proc Natl Acad Sci USA 92 : 6547-6551, 1995 |
5 | Perez-Ruiz M, Ros J, Morales-Ruiz M, Navasa M, Colmenero J, Ruiz-del-Arbol L, Cejudo P, Claria J, Rivera F, Arroyo V, Rodes J, Jimenez W: Vascular endothelial growth factor production in peritoneal macrophages of cirrhotic patients: regulation by cytokines and bacterial lipopolysaccharide. Hepatology 29 : 1057-1063, 1999 DOI ScienceOn |
6 | Tkalcevic J, Novelli M, Phylactides M, Iredale JP, Segal AW, Roes J: Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G. Immunity 12 : 201-210, 2000 DOI ScienceOn |
7 | Prochnau D, Rodel J, Hartmann M, Straube E, Figulla HR: Growth factor production in human endothelial cells after Chlamydia pneumoniae infection. Int J Med Microbiol 294 : 53-57, 2004 DOI ScienceOn |
8 | Pinheiro ML, Feres-Filho EJ, Graves DT, Takiya CM, Elsas MI, Elsas PP, Luz RA: Quantification and localization of platelet-derived growth factor in gingiva of periodontitis patients. J Periodontol 74 : 323-328, 2003 DOI ScienceOn |
9 | Blotnick S, Peoples GE, Freeman MR, Eberlein TJ, Klagsbrun M: T lymphocytes synthesize and export heparinbinding epidermal growth factor-like growth factor and basic fibroblast growth factor, mitogens for vascular cells and fibroblasts: differential production and release by CD4+ and CD8+ T cells. Proc Natl Acad Sci USA 91 : 2890-2894, 1994 |
10 | Kaoru T, Teruo K, Masayasu N: Lipopolysaccharide (LPS)- induced IL-6 production by embryonic fibroblasts isolated and cloned from LPS-responsive and LPS-hyporesponsive mice. Mol Immun 34 : 16-17, 1997 |
11 | Underhill DM, Ozinsky A: Toll-like receptors: key mediators of microbe detection. Curr Opin Immunol 14 : 103-110, 2002 DOI ScienceOn |
12 | Love RM, Jenkinson HF: Invasion of dental tubules by oral bacteria. Crit Rev Oral Biol Med 13(2) : 171-183, 2002 DOI |
13 | Nick D, Gholamreza HG, Jing Z, Lea B, Patrick de B, Hilde R: Secretory leukocyte protease inhibitor promotes the tumorigenic and metastatic potential of cancer cells. Proc Natl Acad Sci USA 100 : 5778-5782, 2003 |
14 | Sunderkotter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C: Macrophages and angiogenesis. J LeukBiol 55 : 410-422, 1994 |
15 | Medzhitov R: Toll-like receptors and innate immunity. Nat Rev Immunol 1 : 135-145, 2001 DOI ScienceOn |
16 | Baird A, Mormede P, Bohlen P: Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggests its identity with macrophage-derived growth factor. Biochem Biophys Res Comm 126 : 358-364, 1985 DOI ScienceOn |
17 | Gospodarowicz D: Fibroblast growth factor. Chemical structure and biologic function. Clin Orthop Relat Res 257 : 231-248, 1990 |
18 | Jin F, Carl FN, Danuta R, Aihao D: Lipopolysaccharide-related stimuli induce expression of the secretory leukocyte protease inhibitor, a macrophage-derived lipopolysaccharide inhibitor. Infection and immunity 66 : 2447-2452, 1998 |
19 | Botero TM, Mantellini MG, Song W, Hanks CT, Nor JE: Effect of lipopolysaccharides on vascular endothelial growth factor expression in mouse pulp cells and macrophage. Eur J Oral Sci 111 : 228-234, 2003 DOI ScienceOn |
20 | Reddy MA, Kim YS, Lanting L, Natarajan R: Reduced growth factor responses in vascular smooth muscle cells derived from 12/15-lipoxygenase-deficient mice. Hypertension 41 : 1294-1300, 2003 DOI ScienceOn |
21 | Folkman J, Klagsbrun M: Angiogenic factors. Science 235 : 442-447, 1987 DOI |
22 | Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246 : 1306-1309, 1989 DOI |
23 | Cozzolino F, Torcia M, Lucibello M, Morbidelli L, Ziche M, Platt J, Fabiani S, Brett J, Sternil D: Interferon-alpha and interleukin 2 synergistically enhance basic fibroblast growth factor synthesis and induce release, promoting endothelial cell growth. J Clin Invest 91 : 2504-2512, 1993 DOI ScienceOn |
24 | Lee SH, Choi BD, Jeong SJ, Jang HS, Kim BO, Lim DS, Park JC, Wang G, Jeong MJ: Increased protein of the secretory leukocyte protease inhibitor (SLPI) and the expression of growth factors in NIH3T3 cells by LPS stimulation. Kor J Electron Micros 36(3) : 165-172, 2006 과학기술학회마을 |
25 | Matsuyama W, Wang L, Farrar WL, Faure M, Yoshimura T: Activation of discoidin domain receptor 1 isoform b with collagen up-regulates chemokine production in human macrophages: role of p38 mitogen-activated protein kinase and NF-kappa B. J Immunol 172 : 2332-2340, 2004 DOI |
26 | Walford G, Loscalzo J: Nitric oxide in vascular biology. J Thromb Haemost 1 : 2112-2118, 2003 DOI ScienceOn |
27 | Kuwabara K, Ogawa S, Matsumoto M, Koga S, Clauss M, Pinsky DJ: Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells. Proc Natl Acad Sci USA 92 : 4606-4610, 1995 |
28 | Slavin J: Fibroblast growth factors At the heart of angiogenesis. Cell Biol Int 19 : 431-444, 1995 DOI ScienceOn |
29 | Fritz H: Human mucus proteinase inhibitor (human MPI). Human seminal inhibitor I (HUSI-I), antileukoprotease (ALP), secretory leukocyte protease inhibitor (SLPI). Biol Chem Hoppe-Seyler 369 : 79-82, 1988 |
30 | Jeffrey RJ, Seed MP, Kircher CH, Willoughby DA, Winkler JD: The codependence of angiogenesis and chronic inflammation. FASEB J 11 : 457-465, 1997 DOI |
31 | Laurie RG, Audrey LA, Diane CS: Construction,non-denaturing affinity purification, and characterization of baculovirally expressed human secretory leukocyte protease inhibitor. Prot Exp & Purif 26 : 179-186, 2002 DOI ScienceOn |
32 | Ohlsson K, Bergenfeldt M, Bjork P: Functional studies of human secretory leukocyte protease inhibitor. Adv Exp Med Biol 240 : 123-131, 1988 |
33 | Shapiro SD, Kobayashi DK, Welgus HG: Identification of TIMP-2 in human alveolar macrophages. Regulation of biosynthesis is opposite to that of metalloproteinases and TIMP-1. J Biol Chem 267 : 13890-13894, 1992 |
34 | Sano C, Shimizu T, Sato K, Kawauchi H, Tomioka H: Effects of secretory leucocyte protease inhibitor on the production of the anti-inflammatory cytokines, IL-10 and transforming growth factor-beta (TGF-b), by lipopolysaccharide-stimulated macrophages. Clin Exp Immunol 121 : 77-85, 2000 DOI |
35 | Bone RC: The pathogenesis of sepsis. Ann Intern 115 : 457-469, 1991 DOI ScienceOn |
36 | Cury JD, Campbell EJ, Lazarus CJ, Albin RJ, Welgus HG: Selective upregulation of human alveolar macrophage collagenase production by lipopolysaccharide and comparison to collagenase production in fibroblasts. J Immunol 14 : 4306-4312, 1988 |
37 | Ross HM, Romrell LJ, Kaye GI: Histology: a text and atlas, 3rd ed. pp. 107-110, 1995 |
38 | Thompson RC, Ohlsson K: Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc Natl Acad Sci USA 83 : 6692-6696, 1986 |
39 | Fink E, Nettelbeck R, Fritz H: Inhibition of mast cell chymase by eglin c and antileukoprotease (HUSI-I). Indications for potential biological functions of these inhibitors. Biol Chem Hoppe-Seyler 367 : 567-571, 1986 DOI ScienceOn |
40 | Jin F, Carl N, Danuta R, Aihao D: Secretory leukocyte protease inhibitor: A macrophage product induced by and antagonistic to bacterial lipopolysaccharide. Cell 48 : 417-426, 1997 DOI ScienceOn |
41 | Polverini PJ: The patholophysiology of angiogenesis. Crit Rev Oral Biol 6 : 230-247, 1998 |
42 | McLaren J, Prentice A, Charnock-Jones DS, Millican SA, Muller KH, Sharkey AM, Smith SK: Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. J Clin Invest 98 : 482-489, 1996 DOI |
43 | Tian JY, Sorensen ES, Butler WT, Lopez CA, Sy MS, Desai NK, Denhardt DT: Regulation of no synthesis induced by inflammatory mediators in RAW264.7 cells: collagen prevents inhibition by osteopontin. Cytokine 12(5) : 450-457, 2000 DOI ScienceOn |
44 | Zhang D, Simmen RC, Michel FJ, Zhao G, Vale-Cruz D, Simmen FA: Secretory leukocyte protease inhibitor mediates proliferation of human endometrial epithelial cells by positive and negative regulation of growth-associated genes. J Biol Chem 277 : 29999-30009, 2002 DOI ScienceOn |